VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Ayuvant

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Harnessing the immune system to beat cancer

  • Biotech & therapeutics
Status
Operatingas of 2026-09-18
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Ayuvant is developing a novel immunotherapy based on RNA-nanoparticles that instruct the immune system on how to recognise and attack cancer cells.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy